Molecular Dynamics Simulations of Self-Assembling Colloids in Fed-State Human Intestinal Fluids and Their Solubilization of Lipophilic Drugs.
human intestinal fluids
lipophilic drugs
lipophilicity
micelles
molecular dynamics simulations
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
02 01 2023
02 01 2023
Historique:
pubmed:
10
11
2022
medline:
4
1
2023
entrez:
9
11
2022
Statut:
ppublish
Résumé
Bioavailability of oral drugs often depends on how soluble the active pharmaceutical ingredient is in the fluid present in the small intestine. For efficient drug discovery and development, computational tools are needed for estimating this drug solubility. In this paper, we examined human intestinal fluids collected in the fed state, with coarse-grained molecular dynamics simulations. The experimentally obtained concentrations in aspirated duodenal fluids from five healthy individuals were used in three simulation sets to evaluate the importance of the initial distribution of molecules and the presence of glycerides in the simulation box when simulating the colloidal environment of the human intestinal fluid. We observed self-assembly of colloidal structures of different types: prolate, elongated, and oblate micelles, and vesicles. Glycerides were important for the formation of vesicles, and their absence was shown to induce elongated micelles. We then simulated the impact of digestion and absorption on the different colloidal types. Finally, we looked at the solubilization of three model compounds of increasing lipophilicity (prednisolone, fenofibrate, and probucol) by calculating contact ratios of drug-colloid to drug-water. Our simulation results of colloidal interactions with APIs were in line with experimental solubilization data but showed a dissimilarity to solubility values when comparing fasted-/fed-state ratios between two of the APIs. This work shows that coarse-grained molecular dynamics simulation is a promising tool for investigation of the intestinal fluids, in terms of colloidal attributes and drug solubility.
Identifiants
pubmed: 36350845
doi: 10.1021/acs.molpharmaceut.2c00710
pmc: PMC9811461
doi:
Substances chimiques
Micelles
0
Colloids
0
Glycerides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
451-460Références
J Chem Theory Comput. 2017 Oct 10;13(10):5039-5053
pubmed: 28787166
J Colloid Interface Sci. 2019 Nov 15;556:266-277
pubmed: 31450021
PLoS One. 2017 Nov 13;12(11):e0187936
pubmed: 29131844
Soft Matter. 2016 Jun 21;12(23):5172-9
pubmed: 27199094
J Chem Inf Model. 2020 Aug 24;60(8):3864-3883
pubmed: 32702979
Nat Methods. 2021 Apr;18(4):382-388
pubmed: 33782607
Int J Pharm. 2012 Jan 17;422(1-2):52-8
pubmed: 22027395
Int J Pharm. 2004 Apr 15;274(1-2):221-32
pubmed: 15072798
J Lipid Res. 2001 Aug;42(8):1273-81
pubmed: 11483629
Compr Physiol. 2013 Jul;3(3):1035-78
pubmed: 23897680
Eur J Pharm Sci. 2018 Jun 15;121:338-346
pubmed: 29902511
Eur J Pharm Sci. 2011 Jul 17;43(4):260-9
pubmed: 21570465
Drug Discov Today. 2005 Feb 15;10(4):289-95
pubmed: 15708748
Angew Chem Int Ed Engl. 2006 Jun 19;45(25):4064-92
pubmed: 16761306
Nat Rev Drug Discov. 2009 Mar;8(3):203-12
pubmed: 19247303
Mol Pharm. 2022 Aug 1;19(8):2868-2876
pubmed: 35776440
J Chem Phys. 2004 Jan 1;120(1):300-11
pubmed: 15267290
J Comput Chem. 2004 Jul 15;25(9):1157-74
pubmed: 15116359
Pharm Res. 2009 Jun;26(6):1456-66
pubmed: 19267186
Mol Pharm. 2016 Oct 3;13(10):3484-3493
pubmed: 27576295
J Phys Chem B. 2017 Dec 7;121(48):10869-10881
pubmed: 29090933
J Colloid Interface Sci. 2021 Apr;587:522-537
pubmed: 33189321
J Colloid Interface Sci. 2022 Jan 15;606(Pt 2):1179-1192
pubmed: 34487937
AAPS J. 2010 Sep;12(3):397-406
pubmed: 20458565
SAR QSAR Environ Res. 2009;20(3-4):241-66
pubmed: 19544191
Mol Pharm. 2012 Feb 6;9(2):237-47
pubmed: 22136289
J Pharm Sci. 2021 Jan;110(1):176-185
pubmed: 33152373
Nat Struct Biol. 2002 Sep;9(9):646-52
pubmed: 12198485
J Pharm Sci. 2016 Feb;105(2):673-681
pubmed: 26228456
Arch Intern Med. 1972 Oct;130(4):506-27
pubmed: 4562149
Chem Rev. 1996 May 9;96(3):1027-1044
pubmed: 11848779
J Comput Chem. 2018 Sep 30;39(25):2118-2125
pubmed: 30306571
Mol Pharm. 2020 Oct 5;17(10):3837-3844
pubmed: 32787279
Pharm Res. 2005 Dec;22(12):2141-51
pubmed: 16247711
Mol Pharm. 2010 Oct 4;7(5):1498-507
pubmed: 20698569
Nature. 1990 Oct 18;347(6294):631-9
pubmed: 2215695
J Med Chem. 2011 Oct 13;54(19):6405-16
pubmed: 21755928
Nat Rev Drug Discov. 2007 Nov;6(11):881-90
pubmed: 17971784
J Chem Theory Comput. 2013 Jan 8;9(1):687-97
pubmed: 26589065
J Phys Chem B. 2007 Jul 12;111(27):7812-24
pubmed: 17569554